Aromatase inhibitor beats tamoxifen for early stage breast cancer
Letrozole better at staving off recurrence and extending survivalRelated items from OnMedicaEarly HRT may raise cancer riskChemo plus tamoxifen better than tamoxifen alone Mortality higher if using paroxetine and tamoxifenBenefit of Herceptin in more breast cancer casesResearchers find clues to breast cancer survival (Source: OnMedica Latest News)
FDA says ulcer drugs may raise diarrhea risk
(Reuters) - Health regulators said ulcer drugs such as AstraZeneca Plc's blockbuster Nexium could increase the risk of clostridium difficile-associated diarrhea (CDAD). (Source: Reuters: Health)
